Cargando…

The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1

Verapamil is used in high doses for the treatment of cluster headache. Verapamil has been described as a P-glycoprotein (P-gp, ABCB1) substrate. We wished to evaluate in vitro whether co administration of a P-gp inhibitor with verapamil could be a feasible strategy for increasing CNS uptake of verap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saaby, Lasse, Tfelt-Hansen, Peer, Brodin, Birger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492727/ https://www.ncbi.nlm.nih.gov/pubmed/26171231 http://dx.doi.org/10.1002/prp2.151

Ejemplares similares

EHMTI-0021. The possible effect of telmisartan on the blood-brain barrier transport of verapamil
por: Saaby, PL, et al.
Publicado: (2014)

IPEC-J2 rMdr1a, a New Cell Line with Functional Expression of Rat P-glycoprotein Encoded by Rat Mdr1a for Drug Screening Purposes
por: Saaby, Lasse, et al.
Publicado: (2020)

Data demonstrating the challenges of determining the kinetic parameters of P-gp mediated transport of low-water soluble substrates
por: Ozgür, Burak, et al.
Publicado: (2017)

The Blood-Brain Barrier Permeability of Lignans and Malabaricones from the Seeds of Myristica fragrans in the MDCK-pHaMDR Cell Monolayer Model
por: Wu, Ni, et al.
Publicado: (2016)

Inhibitory Effects of Neochamaejasmin B on P-Glycoprotein in MDCK-hMDR1 Cells and Molecular Docking of NCB Binding in P-Glycoprotein
por: Pan, Lanying, et al.
Publicado: (2015)

Fitting the Elementary Rate Constants of the P-gp Transporter Network in the hMDR1-MDCK Confluent Cell Monolayer Using a Particle Swarm Algorithm
por: Agnani, Deep, et al.
Publicado: (2011)

The Blood-Brain Barrier Permeability of Six Indole Alkaloids from Uncariae Ramulus Cum Uncis in the MDCK-pHaMDR Cell Monolayer Model
por: Zhang, Yi-Nan, et al.
Publicado: (2017)

Transport of Twelve Coumarins from Angelicae Pubescentis Radix across a MDCK-pHaMDR Cell Monolayer—An in Vitro Model for Blood-Brain Barrier Permeability
por: Yang, Yan-Fang, et al.
Publicado: (2015)

Activation of NMDA receptors in brain endothelial cells increases transcellular permeability
por: Kim, Kyu-Sung, et al.
Publicado: (2022)

Lipopolysaccharide-induced caveolin-1 phosphorylation-dependent increase in transcellular permeability precedes the increase in paracellular permeability
por: Wang, Nan, et al.
Publicado: (2015)

Characterization of Human Colorectal Cancer MDR1/P-gp Fab Antibody
por: Zhang, Xuemei, et al.
Publicado: (2013)

Verapamil and Rifampin Effect on P-Glycoprotein Expression in Hepatocellular Carcinoma
por: Jalali, Amir, et al.
Publicado: (2014)

Erratum to “Characterization of Human Colorectal Cancer MDR1/P-gp Fab Antibody”
por: Zhang, Xuemei, et al.
Publicado: (2014)

Atrial natriuretic peptide enhances microvascular albumin permeability by the caveolae-mediated transcellular pathway
por: Chen, Wen, et al.
Publicado: (2012)

Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells †
por: Teodori, Elisabetta, et al.
Publicado: (2020)

Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells
por: Kyca, Tomáš, et al.
Publicado: (2021)

Endothelial Domes Encapsulate Adherent Neutrophils and Minimize Increases in Vascular Permeability in Paracellular and Transcellular Emigration
por: Phillipson, Mia, et al.
Publicado: (2008)

Actions of external hypertonic urea, ADH, and theophylline on transcellular and extracellular solute permeabilities in frog skin
Publicado: (1975)

The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin
por: Dahlgren, David, et al.
Publicado: (2020)

Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport
por: Sadiq, Muhammad Waqas, et al.
Publicado: (2015)

New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells
por: Braconi, Laura, et al.
Publicado: (2022)

Transcellular Spreading of Tau in Tauopathies
por: Demaegd, Koen, et al.
Publicado: (2018)

Unravelling the complex drug–drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein
por: Ledwitch, Kaitlyn V., et al.
Publicado: (2016)

Expression of MDR1/P glycoprotein in human sarcomas.
por: Vergier, B., et al.
Publicado: (1993)

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Permeability of dura mater: a possible link between cortical spreading depression and migraine pain? A comment
por: Tfelt-Hansen, Peer Carsten
Publicado: (2010)

Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
por: Dupuis, Maria Luisa, et al.
Publicado: (2013)

N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines
por: Vine, Kara L., et al.
Publicado: (2016)

Hypoxia increases expression of selected blood–brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial monolayers
por: Ozgür, Burak, et al.
Publicado: (2022)

Atrial natriuretic peptide increases the albumin permeability of mouse skeletal muscle microcirculation by the caveolae-mediated transcellular pathway
por: Chen, Wen, et al.
Publicado: (2011)

Endothelial β-Catenin Deficiency Causes Blood-Brain Barrier Breakdown via Enhancing the Paracellular and Transcellular Permeability
por: Hussain, Basharat, et al.
Publicado: (2022)

Multiple Origins of Mutations in the mdr1 Gene—A Putative Marker of Chloroquine Resistance in P. vivax
por: Schousboe, Mette L., et al.
Publicado: (2015)

Editorial: “Transcellular Cycles Underlying Neurotransmission”
por: Cerdan, Sebastián, et al.
Publicado: (2015)

Pharmacokinetic Modeling of (R)-[(11)C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates
por: García-Varela, Lara, et al.
Publicado: (2020)

Claudin-4 knockout by TALEN-mediated gene targeting in MDCK cells: Claudin-4 is dispensable for the permeability properties of tight junctions in wild-type MDCK cells
por: Tokuda, Shinsaku, et al.
Publicado: (2017)

P glycoprotein (P-gp) and drug resistance--time for reappraisal?
por: Kaye, S. B.
Publicado: (1993)

Zuo Jin Wan, a Traditional Chinese Herbal Formula, Reverses P-gp-Mediated MDR In Vitro and In Vivo
por: Sui, Hua, et al.
Publicado: (2013)

MicroRNA-298 Reverses Multidrug Resistance to Antiepileptic Drugs by Suppressing MDR1/P-gp Expression in vitro
por: Xie, Yangmei, et al.
Publicado: (2018)

Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
por: Elmeliegy, Mohamed, et al.
Publicado: (2020)

Predicting apparent passive permeability of Caco-2 and MDCK cell-monolayers: A mechanistic model
por: Bittermann, Kai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vom0ccj6n3jm6lqm5htarlve7o